-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Special Symposium on Quality - Identifying and Addressing Underuse in Hematologic Care

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Diversity, Equity, and Inclusion (DEI) , Diseases, Therapies, Adverse Events
Saturday, December 9, 2023: 2:00 PM-3:30 PM
Room 11 (San Diego Convention Center)
Ming Y Lim, MBBChir, University of Utah and Jacob Cogan, MD, University of Minnesota
Lim: Sanofi: Consultancy, Honoraria; Takeda: Consultancy, Honoraria; Alexion: Consultancy, Honoraria.
Underuse of appropriate tests, procedures, and therapies is a significant issue in hematology, resulting in negative outcomes for both individuals and populations.  This special symposium will identify three key areas of underuse in hematology and provide recommendations for addressing them:

  • Retrieval of inferior vena cava (IVC) filters
  • Use of hydroxyurea in patients with sickle cell disease
  • Patient education prior to anticoagulation

This session will encourage all stakeholders to incorporate strategies for identifying and addressing underuse into their quality improvement efforts.

Geoffrey D. Barnes, MD, MSc

University of Michigan, Ann Arbor, MI

Alexandra Power-Hays, MD

Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH

Allison E. Burnett, PharmD

University of New Mexico Health Sciences Center, Albquerque, NM